Table 1.
PA group(n = 108) | Control group(n = 108) | P value | |
---|---|---|---|
Demographic characteristics | |||
Age (years) | 56.1 ± 10.8 | 58.1 ± 9.7 | 0.15 |
Female sex (n, %) | 67 (62.0%) | 63 (58.3%) | 0.58 |
Renal function | |||
BUN (mmol/L) | 56.2 ± 12.1 | 55.9 ± 13.6 | 0.86 |
Scr (µmol/L) | 612.4 ± 102.3 | 631.9 ± 98.6 | 0.15 |
eGFR (mL/minute/1.73 m2) | 34.9 ± 10.3 | 36.2 ± 11.6 | 0.38 |
Pathological staging (n, %) | |||
IgAN I-III | 71 (65.7%) | 75 (69.4%) | 0.56 |
IgAN IV-V | 37 (34.3%) | 31 (28.7%) | 0.38 |
Clinical records (n, %) | |||
Smoking | 45 (41.7%) | 51 (47.2%) | 0.41 |
Drinking | 52 (48.1%) | 49 (45.4%) | 0.68 |
Hypertension | 71 (65.7%) | 69 (63.9%) | 0.78 |
Diabetes mellitus | 68 (63.0%) | 73 (67.6%) | 0.48 |
Myocardial injury | 23 (21.3%) | 26 (24.1%) | 0.63 |
Coronary heart disease | 23 (21.3%) | 27 (25%) | 0.52 |
Pulmonary dysfunction | 16 (14.8%) | 18 (16.7%) | 0.71 |
Stroke | 4 (3.7%) | 6 (5.5%) | 0.52 |
Hemodialysis | 38 (35.2%) | 42 (38.9%) | 0.57 |
Note: Data are median (interquartile range) or number (%).
Abbreviations: IgAN, IgA nephropathy; PA, physical activity; BUN, blood urea nitrogen; Scr, serum creatinine; eGFR, estimated glomerular filtration rate.